Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells

Blood

Volumn 112, Issue 4, 2008, Pages 1214-1222

  Hauben, Ehud ^a   Gregori, Silvia ^a   Draghici, Elena ^a   Migliavacca, Barbara ^a   Olivieri, Stefano ^b   Woisetschläger, Maximilian ^c   Roncarolo, Maria Grazia ^a,d  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Novartis Inst for Biomed Research   (Austria)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CD19 ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; OVALBUMIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VAF 347; VAG 539; [4 (3 CHLORO PHENYL)PYRIMIDIN 2 YL](4 TRIFLUOROMETHYLPHENYL)AMINE; [4 (3 CHLORO PHENYL)PYRIMIDIN 2 YL](4 TRIFLUOROMETHYLPHENYL)CARBAMIC ACID 2 [(2 HYDROXY ETHYL)METHYLAMINO]ETHYLESTER; PYRIMIDINE DERIVATIVE; VAF347;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANIMAL; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

ANIMALS; CELL SURVIVAL; DENDRITIC CELLS; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; PYRIMIDINES; RECEPTORS, ARYL HYDROCARBON; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 51649101135     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-08-109843     Document Type: Article

References (45)

1. Banchereau J, Pascual V, Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity. 2004;20:539-550.
2. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003:21:685-711.
3. Tarbell KV. Yamazaki S, Steinman RM. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol. 2006;18:93-102.
4. Jenkins MK, Khoruts A. Ingulli E. et al. In vivo activation of antigen-specific CD4T cells. Annu Rev Immunol. 2001;19:23-45.
5. Levings MK, Gregori S,Tresoldi E, et al. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+ CD4+ Tr cells. Blood. 2005;105:1162-1169.
6. Penna G, Giarratana N, Amuchastegui S, et al. Manipulating dendritic cells to induce regulatory T cells. Microbes Infect. 2005;7:1033-1039.
7. Roncarolo MG, Levings MK, Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J Exp Med. 2001 ;193:F5-F9.
8. Hauben E, Roncarolo MG. Human CD4+ regulatory T cells and activation-induced tolerance. Microbes Infect. 2005;7:1023-1032.
9. Mahnke K, Enk AH. Dendritic cells: key cells for the induction of regulatory T cells? Curr Top Microbiol Immunol. 2005;293:133-150.
10. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 1998;280:243-248.
11. Akbari O, Freeman GJ, Meyer EH, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med. 2002;8:1024-1032.
12. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, non-proliferating CD4( + ) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000;192:1213-1222.
13. Fisson S. Djelti F, Trenado A. et al. Therapeutic potential of self-antigen-specific CD4+ CD25 + regulatory T cells selected in vitro from a polyclonal repertoire. Eur J Immunol. 2006;36:817-827.
14. Moseman EA, Liang X, Dawson AJ. et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatoryTcells. J Immunol. 2004;173:4433-4442.
15. Ochando JC; Homma C, Yang Y et al. Alloanti-gen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol. 2006;7:652-662.
16. Watanabe N. Wang YH. Lee HK. et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatoryTcells in human thymus. Nature. 2005;436:1181-1185.
17. Fehervari Z; Sakaguchi S. Gontrol of Foxp3+CD25+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol. 2004;16:1769-1780.
18. Kover K, Moore WV. Initiation of rejection of established islet allografts by third-party thyroid allografts and splenic dendritic cells. Diabetes. 1991:40:754-758.
19. Goldstein DR. Toll-like receptors and other links between innate and acquired alloimmunity. Gurr Opin Immunol. 2004;16:538-544.
20. McLellan AD, Brocker EB, Kampgen E. Dendritic cell activation by danger and antigen-specific T-cell signalling. Exp Dermatol. 2000;9:313-322.
21. Barratt-Boyes SM; Thomson AW. Dendritic cells: tools and targets for transplant tolerance. Am J Transplant. 2005;5:2807-2813.
22. Coenen JJ. Koenen HJ. van Rijssen E. Hilbrands LB, Joosten I. Tolerizing effects of co-stimulation blockade rest on functional dominance of CD4+CD25+ regulatory T cells. Transplantation. 2005;79:147-156.
23. Guillonneau C. Aubry V. Renaudin K, et al. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation. 2005;80:255-263.
24. Ricordi C. Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol. 2004;4:259-268.
25. Berney T, Buhler LH, Majno P. Mentha G, Morel P. Immunosuppression for pancreatic islet transplantation. Transplant Proc. 2004;36:362S-366S.
26. Poggioli R, Faradji RN. Ponte G, et al. Quality of life after islet transplantation. Am J Transplant. 2006:6:371-378.
27. Battaglia M, Gregori S. Bacchetta R, Roncarolo MG. Tr1 cells: from discovery to their clinical application. Semin Immunol. 2006;18:120-127.
28. Ettmayer P, Mayer P. Kalthoff F, et al. A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation. Am J Respir Crit Care Med. 2006;173:599-606.
29. Lawrence BP. Denison MS, Novak H, et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low molecular weight compound. Blood. Prepublished on February 12, 2008, as DOI 10.1182/blood-2007-08-109645.
30. Funatake CJ, Marshall NB, Steppan LB. Mourich DV, Kerkvliet Nl. Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlo- rodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells. J Immunol. 2005;175:4184-4188.
31. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008:453:65-71.
32. Fillatreau S, Sweenie CH. McGeachy MJ, Gray D,Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3:944-950.
33. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003;197:489-501.
34. Mizoguchi A, Mizoguchi E, Takedatsu H, Blum-berg RS. Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1 d upregulation. Immunity. 2002;16:219-230.
35. Wakkach A, Fournier N, Brun V, et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003;18:605-617.
36. Sato K, Yamashita N, Yamashita N. Baba M, Mat-suyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity. 2003:18:367-379.
37. Sato K, Yamashita N, Baba M, Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood. 2003;101:3581-3589.
38. Kretschmer K, Apostolou I, Hawiger D, et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005;6:1219-1227.
39. Min WR Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol. 2003;170:1304-1312.
40. Lechler Rl. Ng WF, Camara NO. Infectious tolerance? mechanisms and implications. Transplantation. 2001 ;72:S29-S31.
41. Lan YY, Wang Z, Raimondi G, et al. "Alternatively activated" dendritic cells preferentially secrete IL-10. expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-lg. J Immunol. 2008;177:5868-5877.
42. Zehn D. Cohen CJ, ReiterY, Walden P. Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells. Eur J Immunol. 2004;34:1551-1560.
43. Gregori S, Casorati M, Amuchastegui S, et al. Regulatory T cells induced by 1 alpha,25-dihydroxy vitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2001 ;167:1945-1953.
44. Thomas JM, Eckhoff DE, Contreras JL, et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation. 2000;69:2497-2503.
45. Um HD. Cho YH, Kim DK, et al. TNF-alpha suppresses dentritic cell death and the production of reactive oxygen intermediates induced by plasma withdrawal. Exp Dermatol. 2004;13:282-288.